Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus

Samuel L Murphy1, Maeran Chung-Landers, Marek Honczarenko

  • 1Department of Pathology and Laboratory Medicine, University of Pennsylvania, 354 BRB II/III, 421 Curie Blvd., Philadelphia, Pennsylvania 19104-6142, USA.

Journal of Virology
|April 14, 2006
PubMed

Insights

A specific mutation in the Friend murine leukemia virus (MLV) envelope glycoprotein reduces receptor binding affinity, leading to syncytium induction (SI) and pathology in brain capillary endothelial cells (BCEC). This finding highlights downstream events in cell fusion.

Area of Science:

  • Virology
  • Molecular Biology
  • Pathogenesis

Background:

  • Friend murine leukemia virus (MLV) TR1.3 causes syncytium induction (SI) in brain capillary endothelial cells (BCEC), leading to hemorrhage and death.
  • This pathogenic phenotype is linked to a specific mutation (Trp102Gly) in the envelope glycoprotein (Env).

Purpose of the Study:

  • To elucidate the mechanism of SI induced by MLV TR1.3.
  • To compare the Env function of pathogenic TR1.3 with non-pathogenic MLV FB29, which shares BCEC tropism.

Main Methods:

  • Compared Env expression, stability, and receptor binding affinity of TR1.3 and FB29.
  • Utilized purified envelope receptor binding domain (RBD) and whole-virus particles for binding assays.
  • Assessed the impact of Env changes on superinfection blocking.

Main Results:

  • No significant differences in Env expression or stability between TR1.3 and FB29.
  • TR1.3 Env exhibited >1 log lower binding affinity (K(D)) for its receptor compared to FB29 Env.
  • Reduced receptor affinity of TR1.3 Env correlated with impaired superinfection blocking.

Conclusions:

  • Acquisition of the SI phenotype is directly linked to amino acid changes in retroviral Env that decrease receptor affinity.
  • Events downstream of receptor binding are critical for MLV-induced cell fusion and pathology.
  • This study emphasizes the role of receptor affinity modulation in viral pathogenesis.